Spumavirus isolated from humans
AssigneeThe United States of America as represented by the Department of Health and Human Services
InventorsPaul A. Sandstrom, Thomas M. Folks, Walid M. Heneine, William M. Switzer, Jennifer Brown
Life of this patent
Estimating the term…
Abstract
The present invention comprises a spumavirus isolated from a human. More specifically, the spumavirus of the present invention was isolated from a human who had exposure to nonhuman primates. Importantly, the spumavirus of the present invention or antibodies to the spumavirus can be used to detect the presence of spumavirus or antibodies in body fluids, for pathogenicity studies of related viruses, and as a vector for gene therapies. The spumavirus of the invention can also be used for treatment of conditions in humans due to the presence of rapidly dividing cells and for recombinant live virus vaccination.
Claims3
An isolated spumavirus, wherein the spumavirus is infectious to humans, and wherein the spumavirus is deposited with the ATCC under ATCC Deposit No. VR-2602.
An isolated spumavirus, wherein the spumavirus is infectious to humans, and wherein the spumavirus comprises the nucleic acid sequence of SEQ ID NO:1.
An isolated spumavirus, wherein the spumavirus is infectious to humans, and wherein the spumavirus comprises the nucleic acid sequence of SEQ ID NO:2.
Dependencies are inferred from the claim text.